AME Publishing Company is an integrated academic platform that serves the scientific community, with a focus on bridging the gap between Chinese and international experts. Their mission is to ultimately benefit patients by providing a comprehensive range of products and services. AME offers a variety of high-quality journals, including Translational Gastroenterology and Hepatology (TGH), mHealth, Cardiovascular Diagnosis and Therapy (CDT), and Translational Lung Cancer Research (TLCR).

These journals feature cutting-edge research and contribute to the advancement of their respective fields. In addition to publishing, AME provides editing services to ensure the excellence and integrity of submitted manuscripts. They also offer a webstore where users can access a wide range of medical resources and educational materials.

AME is proud of the recognition and achievements they have received, such as the first impact factor for TGH and the growing influence of their journals within the scientific community. They are dedicated to pursuing excellence and shaping the future of gastroenterology, hepatology, and other medical disciplines. Overall, AME Publishing Company is committed to providing a platform for impactful contributions in the field of medicine while fostering collaboration between experts from different backgrounds